Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Spectrum Pharmaceuticals stock | $1.8

Learn how to easily invest in Spectrum Pharmaceuticals stock.

Spectrum Pharmaceuticals Inc is a biotechnology business based in the US. Spectrum Pharmaceuticals shares (SPPI) are listed on the NASDAQ and all prices are listed in US Dollars. Spectrum Pharmaceuticals employs 175 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Spectrum Pharmaceuticals

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – SPPI – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Spectrum Pharmaceuticals stock price (NASDAQ: SPPI)

Use our graph to track the performance of SPPI stocks over time.

Spectrum Pharmaceuticals shares at a glance

Information last updated 2021-10-23.
Latest market close$1.80
52-week range$1.92 - $5.24
50-day moving average $2.15
200-day moving average $2.97
Wall St. target price$6.20
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.21

Buy Spectrum Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Robinhood
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Moomoo
Stocks
$0
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Webull
Stocks, Options, ETFs
$0
0%
Get two free stocks valued between $3.00 and $300 with a deposit to any new account.
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Spectrum Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Spectrum Pharmaceuticals price performance over time

Historical closes compared with the close of $1.8 from 2021-10-27

1 week (2021-10-21) -9.55%
1 month (2021-09-28) -22.41%
3 months (2021-07-28) -45.45%
6 months (2021-04-28) -41.18%
1 year (2020-10-27) -47.21%
2 years (2019-10-25) -77.07%
3 years (2018-10-26) 12.11
5 years (2016-10-27) 3.77

Spectrum Pharmaceuticals financials

Revenue TTM $109.3 million
Gross profit TTM $0
Return on assets TTM -51.46%
Return on equity TTM -153.89%
Profit margin 0%
Book value $0.68
Market capitalisation $326.5 million

TTM: trailing 12 months

Shorting Spectrum Pharmaceuticals shares

There are currently 18.2 million Spectrum Pharmaceuticals shares held short by investors – that's known as Spectrum Pharmaceuticals's "short interest". This figure is 15% up from 15.8 million last month.

There are a few different ways that this level of interest in shorting Spectrum Pharmaceuticals shares can be evaluated.

Spectrum Pharmaceuticals's "short interest ratio" (SIR)

Spectrum Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Spectrum Pharmaceuticals shares currently shorted divided by the average quantity of Spectrum Pharmaceuticals shares traded daily (recently around 2.7 million). Spectrum Pharmaceuticals's SIR currently stands at 6.78. In other words for every 100,000 Spectrum Pharmaceuticals shares traded daily on the market, roughly 6780 shares are currently held short.

However Spectrum Pharmaceuticals's short interest can also be evaluated against the total number of Spectrum Pharmaceuticals shares, or, against the total number of tradable Spectrum Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Spectrum Pharmaceuticals's short interest could be expressed as 0.11% of the outstanding shares (for every 100,000 Spectrum Pharmaceuticals shares in existence, roughly 110 shares are currently held short) or 0.1361% of the tradable shares (for every 100,000 tradable Spectrum Pharmaceuticals shares, roughly 136 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Spectrum Pharmaceuticals.

Find out more about how you can short Spectrum Pharmaceuticals stock.

Spectrum Pharmaceuticals share dividends

We're not expecting Spectrum Pharmaceuticals to pay a dividend over the next 12 months.

Have Spectrum Pharmaceuticals's shares ever split?

Spectrum Pharmaceuticals's shares were split on a 1:25 basis on 5 September 2002. So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Spectrum Pharmaceuticals shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for Spectrum Pharmaceuticals shares which in turn could have impacted Spectrum Pharmaceuticals's share price.

Spectrum Pharmaceuticals share price volatility

Over the last 12 months, Spectrum Pharmaceuticals's shares have ranged in value from as little as $1.92 up to $5.24. A popular way to gauge a stock's volatility is its "beta".

SPPI.US volatility(beta: 2.09)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Spectrum Pharmaceuticals's is 2.0921. This would suggest that Spectrum Pharmaceuticals's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Spectrum Pharmaceuticals overview

Spectrum Pharmaceuticals, Inc. , a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include ROLONTIS, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor for non-small cell lung cancer tumors with various mutations; and Anti-CD20-IFNa, an antibody-interferon fusion molecule directed against CD20 that is in Phase I development for the treatment of patients with relapsed or refractory non-Hodgkin's lymphoma, including diffuse large B-cell lymphoma. It has co-development, commercialization, and in-license agreements with Hanmi Pharmaceutical Co. Ltd. ; a patent and technology license agreement with The University of Texas M. D.

Frequently asked questions

What percentage of Spectrum Pharmaceuticals is owned by insiders or institutions?
Currently 1.501% of Spectrum Pharmaceuticals shares are held by insiders and 68.542% by institutions.
How many people work for Spectrum Pharmaceuticals?
Latest data suggests 175 work at Spectrum Pharmaceuticals.
When does the fiscal year end for Spectrum Pharmaceuticals?
Spectrum Pharmaceuticals's fiscal year ends in December.
Where is Spectrum Pharmaceuticals based?
Spectrum Pharmaceuticals's address is: 11500 South Eastern Avenue, Henderson, NV, United States, 89052
What is Spectrum Pharmaceuticals's ISIN number?
Spectrum Pharmaceuticals's international securities identification number is: US84763A1088
What is Spectrum Pharmaceuticals's CUSIP number?
Spectrum Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 640656104

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site